ArticleImmunity, inflammation and disease2024

Dexmedetomidine activates the PKA/CREB pathway and inhibits proinflammatory factor expression through β2 adrenergic receptors.

Baocheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.